Literature DB >> 27704264

Analysis of molecular alterations in laterally spreading tumors of the colorectum.

Tamotsu Sugai1, Wataru Habano2, Ryo Takagi3, Hiroo Yamano3, Makoto Eizuka4, Noriyuki Arakawa4, Yayoi Takahashi4, Eiichiro Yamamoto5,6, Keisuke Kawasaki7, Syunichi Yanai7, Kazuyuki Ishida4, Hiromu Suzuki5, Takayuki Matsumoto7.   

Abstract

BACKGROUND: Colorectal laterally spreading tumors (LSTs) are classified into LST-Gs and LST-NGs, according to macroscopic findings. In the present study, we determined the genetic and epigenetic alterations within colorectal LSTs and protruding adenomas.
METHODS: A crypt isolation method was used to isolate DNA from tumors and normal glands of 73 macroscopically verified colorectal LSTs (histologically defined adenomas; 38 LST-Gs and 35 LST-NGs) and 36 protruding adenomas. The DNA was processed using polymerase chain reaction (PCR) microsatellite assays, single-strand conformation polymorphism (SSCP) assays, and pyrosequencing to detect chromosomal allelic imbalance (AI), mutations in APC, KRAS, and TP53, and the methylation of MLH1, MGMT, CDKN2A, HPP1, RASSF2A, SFRP1, DKK1, ZFP64, and SALL4 genes. In addition, methylation status was examined using the following set of markers: MIN1, MINT2, MINT31, MLH1, and CDKN2A (with classification of negative/low and high). Microsatellite instability (MSI) was also examined.
RESULTS: 5q AI and methylation of the SFRP1 and SALL4 genes were common molecular events in both LST-Gs and LST-NGs. Neither MSI nor mutations in BRAF ware observed in the LSTs. TP53 mutations were rarely found in LSTs. The frequencies of KRAS and APC mutations and the methylation levels of ZFP64, RASSF2A, and HPP1 genes were significantly higher in LST-Gs than in LST-NGs. Protruding adenomas showed alterations common to LST-Gs. Negative/low methylation status was common among the three types of tumors.
CONCLUSION: Combined genetic and epigenetic data suggested that the molecular mechanisms of tumorigenesis were different between LST-Gs and LST-NGs.

Entities:  

Keywords:  APC; Colon; KRAS; Laterally spreading tumor; Loss of heterozygosity; Methylation

Mesh:

Substances:

Year:  2016        PMID: 27704264     DOI: 10.1007/s00535-016-1269-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  41 in total

1.  Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum.

Authors:  T Uraoka; Y Saito; T Matsuda; H Ikehara; T Gotoda; D Saito; T Fujii
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

2.  Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.

Authors:  Sakiko Hiraoka; Jun Kato; Masashi Tatsukawa; Keita Harada; Hideyuki Fujita; Tamiya Morikawa; Hidenori Shiraha; Yasushi Shiratori
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

3.  Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm.

Authors:  S Tanaka; K Haruma; S Oka; R Takahashi; M Kunihiro; Y Kitadai; M Yoshihara; F Shimamoto; K Chayama
Journal:  Gastrointest Endosc       Date:  2001-07       Impact factor: 9.427

4.  Synergistic cooperation of Sall4 and Cyclin D1 in transcriptional repression.

Authors:  Johann Böhm; Frank J Kaiser; Wiktor Borozdin; Reinhard Depping; Jürgen Kohlhase
Journal:  Biochem Biophys Res Commun       Date:  2007-03-19       Impact factor: 3.575

5.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma.

Authors:  Katsuhiko Nosho; Hiroyuki Yamamoto; Taiga Takahashi; Masashi Mikami; Keiichi Hizaki; Tadateru Maehata; Hiroaki Taniguchi; Satoshi Yamaoka; Yasushi Adachi; Fumio Itoh; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Hum Pathol       Date:  2008-03-04       Impact factor: 3.466

7.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Authors:  O Aguilera; M F Fraga; E Ballestar; M F Paz; M Herranz; J Espada; J M García; A Muñoz; M Esteller; J M González-Sancho
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

8.  The Wnt antagonist sFRP1 in colorectal tumorigenesis.

Authors:  Germaine M Caldwell; Carolyn Jones; Karl Gensberg; Shamem Jan; Robert G Hardy; Philip Byrd; Shaheen Chughtai; Yvonne Wallis; Glenn M Matthews; Dion G Morton
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

Review 9.  Emerging concepts in colorectal neoplasia.

Authors:  Jeremy R Jass; Vicki L J Whitehall; Joanne Young; Barbara A Leggett
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas.

Authors:  G M Caldwell; C E Jones; P Taniere; R Warrack; Y Soon; G M Matthews; D G Morton
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

View more
  3 in total

1.  [Expression of Wnt and integrin pathways in colorectal laterally spreading tumors and their correlation with endoscopic subtypes].

Authors:  Jie Wu; Ji-Rong Huo; Dong Wang; Chun-Lian Wang; Liang Lv
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

2.  High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer.

Authors:  Jeong Eun Kim; Jaeyong Choi; Chang-Ohk Sung; Yong Sang Hong; Sun Young Kim; Hyunjung Lee; Tae Won Kim; Jong-Il Kim
Journal:  Exp Mol Med       Date:  2021-03-22       Impact factor: 8.718

3.  Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer.

Authors:  Mengxuan Zhu; Pengfei Zhang; Shan Yu; Cheng Tang; Yan Wang; Zhenbin Shen; Weidong Chen; Tianshu Liu; Yuehong Cui
Journal:  J Exp Clin Cancer Res       Date:  2022-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.